In today's world, NOD1 is a highly relevant topic that has captured the attention of people of all ages and backgrounds. The importance of NOD1 has led to a wide range of studies, debates and analyzes in different fields, from science and technology to politics and culture. Over time, NOD1 has become a central point of interest for society, generating both excitement and concern in equal measure. In this article, we will thoroughly explore the most relevant aspects of NOD1 and analyze its impact on modern society.
Protein receptor that recognizes bacterial molecules and stimulates an immune reaction
Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is a protein receptor that in humans is encoded by the NOD1gene.[5][6] It recognizes bacterial molecules and stimulates an immune reaction.[7]
NOD1 protein contains a caspase recruitment domain (CARD). NOD1 is a member of NOD-like receptor protein family and is a close relative of NOD2. NOD1 is an intracellular pattern recognition receptor, which is similar in structure to resistant proteins of plants, and mediates innate and acquired immunity by recognizing molecules containing D-glutamyl-meso-diaminopimelic acid (iE-DAP) moiety, including bacterial peptidoglycan. Nod1 interacts with RIPK2 through the CARDs of both molecules (See the structure of the NOD1 CARD in the right panel). Stimulation of NOD1 by iE-DAP containing molecules results in activation of the transcription factor NF-κB.
Yoo NJ, Park WS, Kim SY, Reed JC, Son SG, Lee JY, Lee SH (December 2002). "Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1". Biochemical and Biophysical Research Communications. 299 (4): 652–8. doi:10.1016/S0006-291X(02)02714-6. PMID12459189.
Matsuda A, Suzuki Y, Honda G, Muramatsu S, Matsuzaki O, Nagano Y, Doi T, Shimotohno K, Harada T, Nishida E, Hayashi H, Sugano S (May 2003). "Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways". Oncogene. 22 (21): 3307–18. doi:10.1038/sj.onc.1206406. PMID12761501. S2CID38880905.